Does hepatitis C virus cause severe liver disease only in people who drink alcohol?

Lancet Infectious Diseases

Volumn 2, Issue 5, 2002, Pages 303-309

  Vento, Sandro ^a,b   Cainelli, Francesca ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ALCOHOL CONSUMPTION; DISEASE ASSOCIATION; DISEASE COURSE; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER HISTOLOGY; MEASUREMENT; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 0036242347     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(02)00271-2     Document Type: Note

References (125)

1. Isolation of a cDNA clone derived from blood borne non-A, non-B viral hepatitis genome
2. Hepatitis C virus antibodies among risk groups in Spain
3. Prevalence of antibodies to hepatitis C in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis
4. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellutar carcinoma
5. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
6. Seminar: Hepatitis C
7. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
8. Natural history of hepatitis C
9. Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users
10. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus
11. High prevalence of hepatitis C virus infection in a small central Italian town: Lack of evldence of parenteral exposure
12. Prevalence of hepatitis B and C markers in the South-east of Spain: An unlinked community-based serosurvey of 2,203 adults
13. Hepatitis C in a French population based survey, 1994: Seroprevalence, frequency ofviremia, genotype distribution, and risk factors
14. Epidemiology of hepatitis C virus infection in an area of Southern Italy
15. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in Southern Italy
16. Hepatitis C infection in an Italian population not selected for risk factors
17. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: Report from the Dionysos study
18. Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in Southern Italy: A population-based study
19. Impact of hepatitis C virus infection on healthy subjects on an Italian island
20. Hepatitis C virus infection and alanine aminotransferase levels in the general population: A survey in a southern Italian town
21. Community-based seroepidemiological survey of HCV infection in Catalonia, Spain
22. The natural history of hepatitis C: Clinical experiences
23. Natural history and etiology of liver disease in patients with previous community-acquired acute non-A, non-B hepatitis
24. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin
25. 45-Year follow-up of hepatitis C virus infection in healthy young adults
26. The natural history of hepatitis C virus infection: Host, viral, and environment factors
27. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975
28. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985
29. The epidemiology of hepatitis C in a UK health regional population of 5.12 million
30. The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders
31. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
32. Long-term follow-up of NANB (type C) post-transfusion hepatitis
33. Clinical outcomes after transfusion-associated hepatitis C
34. Long-term mortality after transfusion-associated non-A, non-B hepatitis
35. Natural history of liver fibrosis progression in patients with chronic hepatitis C
36. Impact of alcohol on the histological and clinical progression of hepatitis C infection
37. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity
38. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients
39. Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: Results of a case-control study
40. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C
41. The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse
42. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis
43. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection
44. Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C
45. Liver histology in hepatitis C infection: A comparison between patients with persistently normal or abnormal transaminases
46. Alcohol intake increases hepatitis C virus-induced hepatocellular injury
47. Chronic hepatitis C: Effect of alcohol on hepatitis activity and viral titre
48. The effect of light drinking on HCV liver disease: The jury is still out
49. Prognosis of chronic hepatitis C: Results of a large prospective cohort study
50. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C
51. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis
52. A prospective study on hepatocellular carcinoma in liver cirrhosis: Respective roles of alcohol and hepatitis C virus infection
53. Relation between markers for viral hepatitis and clinical features of lapanese patients with hepatocellular carcinoma: Possible role of alcohol in promoting carcinogenesis
54. Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma: Its relationship to alcoholic drinking and the age of transfusion
55. Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients
56. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C: A long term follow-up study after histologic diagnosis
57. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: The role of HCV genotypes and the synergism with hepatitis B virus and alcohol
58. Clinical characteristics of patients in their 40s with HCV antibody-positive hepatocellular carcinoma
59. Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption
60. Drinking habits of subjects with hepatitis C virus-related chronic liver disease: Prevalence and effect on clinical, virological and pathological aspects
61. Effects of alcohol on the replication of hepatitis C virus
62. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C
63. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection
64. Influence of chronic alcohol abuse on hepatitis C virus replication
65. Difference in quasispecies of the hypervariable region 1 of hepatitis C virus between alcoholic and non-alcoholic patients
66. Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: Mechanisms of liver cell injury in chronic hepatitis C virus infection
67. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokinee-xpressing plasmids
68. Reduced alloreative T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFN gamma levels
69. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection
70. Hepatic iron overload in patients with chronic viral hepatitis: Role of HFE gene mutations
71. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C
72. Chronic hepatitis C is mild in menstruating women
73. Conference summary: Consensus Conference on alcohol dependence and the role of pharmacotherapy in its treatment
74. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: A multicenter Italian study
75. Alcohol and liver disease
76. Female sex and the risk of liver cirrhosis
77. Attributable risk for symptomatic liver cirrhosis in Italy
78. Factors determining cirrhosis in alcoholic liver disease
79. Prediction of risk of liver disease by alcohol intake, sex and age: A prospective population study
80. Risk of fatty liver infiltration or cirrhosis of the liver in relation to ethanol consumption: A case-control study
81. Excess weight as a risk factor for alcoholic liver disease
82. Diagnostic utility of laboratory tests in alcoholic liver disease
83. The alcoholic patient with hepatitis C virus infection
84. Alcoholism in hereditary hemochromatosis revisited: Prevalence and clinical consequences among homozygous siblings
85. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis
86. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice
87. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver
88. Liver steatosis and chronic hepatitis C: A spurious association?
89. Combination of steatosis and alcohol intake is the main determinant of fibrosis progression in patients with hepatitis C
90. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
91. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
92. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening
93. Transfusion associated hepatitis C and G in pediatric patients identified through a universal look-back approach
94. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia
95. Natural history of hepatitis C
96. Hepatitis virus infections in heart transplant recipients: Epidemiology, natural history, characteristics, and impact on survival
97. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin
98. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection
99. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection
100. Hepatitis C is more severe in drug users with human immunodeficiency virus infection
101. Clotting factor concentrates and immune function in haemophilic patients
102. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus: The multicenter hemophilia cohort study
103. The progression of HCV-associated liver disease in a cohort of hemophilic patients
104. The natural history of chronic hepatitis C in hemophiliacs
105. Mortality from liver cancer and liver disease in hemophiliac men and boys in UK given blood products contaminated with hepatitis C
106. Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection
107. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
108. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A longterm retrospective cohort study
109. Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: Impact of protease inhibitor therapy
110. Presence of HIV-1 in human parenchymal and non-parenchymal liver cells in vivo
111. Role of endogenous interferon in hepatitis C virus (HCV) infection and in coinfection by HIV and HCV
112. Altered iron metabolism in HIV infection: Mechanisms, possible consequences and proposals for management
113. Interactions between metabolic disorders (diabetes, gallstones, and dyslipidaemia) and the progression of chronic hepatitis C virus infection to cirrhosis and hepatocellular carcinoma: A cross-sectional multicentre survey
114. Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease
115. Hepatitis C: The virus that created hepatology
116. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels
117. Is the natural history of hepatitis C virus carriers really benign?
118. Host genetic factors influence disease progression in chronic hepatitis C
119. Helicobacter infection and cirrhosis in hepatitis C virus carriage: Is it an innocent bystander or a troublemaker?
120. The habitual diet in rural and urban Cameroon
121. Alcohol consumption amongst South African farm workers: A challenge for post-apartheid health sector transformation
122. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine
123. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors
124. Alcohol consumption and mortality among middle-aged and elderly US adults